Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Insulin glargine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lantus 100units/ml inj 3ml pre-filled SoloStar pens
0601012V0BBAEAD
|
Insulin Lantus | Insulin glargine | Endocrine System | 183,126 |
|
Toujeo 300units/ml inj 1.5ml pre-filled SoloStar pens
0601012V0BCAAAE
|
Toujeo | Insulin glargine | Endocrine System | 75,459 |
|
Abasaglar KwikPen 100units/ml inj 3ml pre-filled pens
0601012V0BDACAD
|
Abasaglar | Insulin glargine | Endocrine System | 63,399 |
|
Lantus 100units/ml solution for injection 3ml cartridges
0601012V0BBAAAA
|
Insulin Lantus | Insulin glargine | Endocrine System | 34,860 |
|
Toujeo 300units/ml inj 3ml pre-filled DoubleStar pens
0601012V0BCABAF
|
Toujeo | Insulin glargine | Endocrine System | 27,521 |
|
Semglee 100units/ml inj 3ml pre-filled pens
0601012V0BEAAAD
|
Semglee | Insulin glargine | Endocrine System | 12,922 |
|
Insulin glargine 100units/ml inj 3ml pf dispos dev
0601012V0AAADAD
|
Insulin glargine | Insulin glargine | Endocrine System | 10,209 |
|
Abasaglar 100units/ml solution for injection 3ml cartridges
0601012V0BDABAA
|
Abasaglar | Insulin glargine | Endocrine System | 4,143 |
|
Insulin glargine 100units/ml inj 3ml cartridges
0601012V0AAAAAA
|
Insulin glargine | Insulin glargine | Endocrine System | 3,478 |
|
Lantus 100units/ml solution for injection 10ml vials
0601012V0BBABAB
|
Insulin Lantus | Insulin glargine | Endocrine System | 2,207 |
|
Insulin glargine 300units/ml inj 1.5ml pf dispos dev
0601012V0AAAEAE
|
Insulin glargine | Insulin glargine | Endocrine System | 913 |
|
Insulin glargine 100units/ml inj 10ml vials
0601012V0AAABAB
|
Insulin glargine | Insulin glargine | Endocrine System | 329 |
|
Insulin glargine 300units/ml inj 3ml pf disposable devices
0601012V0AAAFAF
|
Insulin glargine | Insulin glargine | Endocrine System | 220 |
|
Abasaglar Tempo Pen 100units/ml inj 3ml pre-filled pens
0601012V0BDADAD
|
Abasaglar | Insulin glargine | Endocrine System | 30 |
|
Lantus 100units/ml inj 3ml OptiClik cartridges
0601012V0BBADAA
|
Insulin Lantus | Insulin glargine | Endocrine System | No data available |
|
Lantus 100units/ml inj 3ml pre-filled OptiSet pens
0601012V0BBACAD
|
Insulin Lantus | Insulin glargine | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.